Listed

Satellos Bioscience Inc.

MSLENasdaqCIK 1421642HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$9.8m, FY2025
Shareholders' equity$27.8m, FY2025
Line itemUnitperiod not labelled2023-12-31period not labelled2024-12-31FY20252025-12-31
Cash and equivalents$m16.7Cash and equivalents, period not labelled, at 2023-12-31$16.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure40.1Cash and equivalents, period not labelled, at 2024-12-31$40.1m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure9.8Cash and equivalents, FY2025, at 2025-12-31$9.8m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure
Current assets$m30.5Current assets, period not labelled, at 2023-12-31$30.5m. XBRL concept ifrs-full:CurrentAssets. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure50.7Current assets, period not labelled, at 2024-12-31$50.7m. XBRL concept ifrs-full:CurrentAssets. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure31.9Current assets, FY2025, at 2025-12-31$31.9m. XBRL concept ifrs-full:CurrentAssets. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure
Total assets$m33.5Total assets, period not labelled, at 2023-12-31$33.5m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure50.7Total assets, period not labelled, at 2024-12-31$50.7m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure31.9Total assets, FY2025, at 2025-12-31$31.9m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure
Current liabilities$m2.7Current liabilities, period not labelled, at 2023-12-31$2.7m. XBRL concept ifrs-full:CurrentLiabilities. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure3.6Current liabilities, period not labelled, at 2024-12-31$3.6m. XBRL concept ifrs-full:CurrentLiabilities. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure4.1Current liabilities, FY2025, at 2025-12-31$4.1m. XBRL concept ifrs-full:CurrentLiabilities. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure
Total liabilities$m2.7Total liabilities, period not labelled, at 2023-12-31$2.7m. XBRL concept ifrs-full:Liabilities. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure3.6Total liabilities, period not labelled, at 2024-12-31$3.6m. XBRL concept ifrs-full:Liabilities. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure4.1Total liabilities, FY2025, at 2025-12-31$4.1m. XBRL concept ifrs-full:Liabilities. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure
Shareholders' equity$m30.8Shareholders' equity, period not labelled, at 2023-12-31$30.8m. XBRL concept ifrs-full:Equity. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure47.2Shareholders' equity, period not labelled, at 2024-12-31$47.2m. XBRL concept ifrs-full:Equity. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure27.8Shareholders' equity, FY2025, at 2025-12-31$27.8m. XBRL concept ifrs-full:Equity. 40-F filed 2026-03-27, accession 0001104659-26-035729.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.